주식/증권
➡️ 중립
4DMT Announces New Employment Inducement Grants
요약
EMERYVILLE, Calif., May 15, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that on May 12, 2026, the compensation committee of the Company’s board of directors granted 14 new non-executive employees 141,100 Restricted Stock Units (RSUs). The RSUs were